US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

